IDN & Bio/Pharma Partnering Summit

August 16-17, 2022 | USA

IDN & Bio
A think-tank for industry pioneers, showcasing novel case studies and innovative partnership models that deliver enhanced value, manage costs and improve quality

Spotlight

Lung cancer rates are dropping, but it remains second-most-common cancer in both men and women (excluding skin cancer). About 14 percent of all new cancers are lung cancers, and most of those are NSCLC. But today, the outlook for patients is improving, in large part because immunotherapy is transforming the way cancers are treated.


OTHER PAST CONFERENCES

Transform your data management, informatics systems utilisation and R&D processes.

November 15-17, 2022 | USA

The global laboratory informatics market is forecast to reach $3.8bn by 2024, with the growth driven primarily by the enhanced importance of data analytics for drug discovery, increasing regulatory requirements and the greater utilization of automation in the lab.

Pharmaceutics and Advanced Drug Delivery Systems

September 1-2, 2022 | Italy

4th International Conference on Pharmaceutics and Advanced Drug Delivery Systems will welcome you to Rome, Italy September 1-2, 2022.

GLOBAL CONFERENCE ON PHARMACEUTICALS AND CLINICAL RESEARCH

November 14-16, 2022 | France

On behalf of Scientex Conferences we cordially invite you to attend “Global Conference on Pharmaceuticals and Clinical Research” on November 14-16, 2022 at Paris, France. It mainly focuses on the theme “Futuristic Advancements in Pharmaceuticals and Clinical Research”.

World Drug Safety Congress Europe

September 27-29, 2022 | USA

The World Drug Safety Congress Europe is empowering patients, physicians, pharma, biotech and consumers to make the best drug safety decisions.

Spotlight

Lung cancer rates are dropping, but it remains second-most-common cancer in both men and women (excluding skin cancer). About 14 percent of all new cancers are lung cancers, and most of those are NSCLC. But today, the outlook for patients is improving, in large part because immunotherapy is transforming the way cancers are treated.

resources